First Structural Model of Full-Length Human Tissue-Plasminogen Activator: A SAXS Data-Based Modeling Study

被引:22
|
作者
Rathore, Yogendra S. [1 ]
Rehan, Mohammad [1 ]
Pandey, Kalpana [1 ]
Sahni, Girish [1 ]
Ashish [1 ]
机构
[1] Inst Microbial Technol CSIR, Dept Prot Sci & Engn, Chandigarh 160036, India
来源
JOURNAL OF PHYSICAL CHEMISTRY B | 2012年 / 116卷 / 01期
关键词
SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; ESCHERICHIA-COLI; CATALYTIC DOMAIN; KRINGLE-2; DOMAIN; GLYCOSYLATION; RESOLUTION; FIBRIN; VARIANTS;
D O I
10.1021/jp207243n
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Human tissue-plasminogen activator (t-PA) is a multidomain glycoprotein which holds high biomedical value due to its therapeutic role in clot-specific fibrinolysis. Although atomic-resolution structures of individual domains except Kringlel are available, no structural information is available on how these domains and glycosylation are oriented in space relative to each other in the full-length protein. SAXS intensity profile acquired from samples of t-PA was used to "steer" structures of individual domains and the homology model of the first kringle domain to generate a structural model of the protein part of t-PA. Differences in the shape profiles of SAXS data-based dummy atom and proteinogenic models aided in grafting glycosylated moieties on the coordinates of t-PA. According to previously reported mutagenesis-rendered altered functional profiles, normal-mode analysis of our model revealed that the fibrin binding F/E domains "communicate" with the active-site in the P domain via Kringle2, while Kringlel is positioned away from these long-distance interactions.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 25 条
  • [21] Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing
    Friedman-Klabanoff, Deanna J.
    Berry, Andrea A.
    Travassos, Mark A.
    Cox, Catherine
    Zhou, Yingjun
    Mo, Annie X.
    Nomicos, Effie Y. H.
    Deye, Gregory A.
    Pasetti, Marcela F.
    Laurens, Matthew B.
    VACCINE, 2021, 39 (08) : 1195 - 1200
  • [22] A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow (vol 10, 064101, 2016)
    Dawson, A.
    Dyer, C.
    Macfie, J.
    Davies, J.
    Karsai, L.
    Greenman, J.
    Jacobsen, M.
    BIOMICROFLUIDICS, 2018, 12 (01):
  • [23] FIRST DETECTION OF GENOTYPE 3 AND 4 HEPATITIS E VIRUS (HEV) RNA AMONG THE GENERAL POPULATION IN CAMBODIA: FULL-LENGTH SEQUENCE OF HEV ISOLATE, PREVALENCE AND INCIDENCE OF HEV INFECTION WERE CLARIFIED BASED ON THE SERO-EPIDEMIOLOGICAL STUDY
    Yamada, H.
    Takahashi, K.
    Lim, O.
    Matsuo, J.
    Kaishima, T.
    Fujii, T.
    Katayama, K.
    Svay, S.
    Tanaka, J.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S554 - S555
  • [24] Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins
    Garcia-Arriaza, Juan
    Marin, Maria Q.
    Merchan-Rubira, Jesus
    Mascaraque, Sara M.
    Medina, Miguel
    Avila, Jesus
    Hernandez, Felix
    Esteban, Mariano
    VACCINES, 2020, 8 (01)
  • [25] First-in-human phase 1/2 study of MCLA-128, a full length IgG1 bispecific antibody targeting HER2 and HER3: Final phase 1 data and preliminary activity in HER2+metastatic breast cancer (MBC).
    Alsina, Maria
    Boni, Valentina
    Schellens, Jan H. M.
    Moreno, Victor
    Bol, Kees
    Westendorp, Martine
    Sirulnik, L. Andres
    Tabernero, Josep
    Calvo, Emiliano
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35